We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immune Abnormalities Meet Diagnostic Criteria for Myalgic Encephalomyelitis

By LabMedica International staff writers
Posted on 16 Jan 2014
Print article
Image: FACSCalibur flow cytometer (Photo courtesy of Becton Dickinson).
Image: FACSCalibur flow cytometer (Photo courtesy of Becton Dickinson).
Immunological abnormalities have been identified in Myalgic Encephalomyelitis, also known as Chronic Fatigue Syndrome (ME/CFS) patients and significant developments have been made to the diagnostic criteria

Potential immunological markers have not been assessed in patients fulfilling these latest clinical requirements and therefore there is a need to evaluate immunological parameters in patients that also fulfill the latest diagnostic criteria available known as the International Consensus Criteria (ICC).

Immunologists at Griffith University (Gold Coast, Australia) recruited 63 participants of which 41 were ME/CFS patients and 22 were healthy controls. Whole blood samples were collected from all participants. With the exception of Natural Killer (NK) cell phenotyping experiments, whole blood was used for all phenotyping studies.

For all flow cytometer experiments, the monoclonal antibodies were fluorescently labeled with fluorescein isothiocyanate, phycoerythrin, allophycocyanin and peridinin chlorophyll, and analysis was performed on a four-color flow cytometer. The activity of NK cells was measured using a well-known flow cytometric method stained with annexin V and 7-AAD (Becton Dickinson (BD); San Diego, CA, USA) and analyzed on the BD fluorescence-activated cell sorting (FACS) Calibur flow cytometer.

In patients with ME/CFS, NK cell activity was significantly reduced in comparison to healthy controls. Measures of NK cell lytic proteins did not yield any significance difference between the groups. A significant increase in regulatory T-cells (Tregs) was observed ME/CFS patients in comparison to healthy controls. A significant decrease in cluster of differentiation CD39+ Tregs was observed in one group of ME/CFS patients in comparison to healthy controls. No significant differences were observed in B-cells, NK cells and plasmacytoid and myeloid (DC) phenotypes.

The authors concluded that differences could be found in human neutrophil antigens and expression of natural killer cell receptors between patient groups. Highly significant correlations were also found between physical status and some immune parameters in ICC defined patients. This preliminary investigation on different diagnostic criteria suggests that the ICC may be more effective in detecting salient differences in the immune system. The study was published on November 14, 2013, in the Journal of Molecular Biomarkers & Diagnosis.

Related Links:

Griffith University
Becton Dickinson 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.